Table 2.
Distribution of metabolic syndrome and its components in the case group and the control group
| Metabolic abnormalities | Case group (N = 104) | Control group (N = 103) | ||
|---|---|---|---|---|
| n | % (95% CI) | n | % (95% CI) | |
| Type of metabolic abnormalities | ||||
| Increased WC | 39 | 37.5 (28.8–47.1) | 21 | 20.4 (13.7–29.2) |
| Elevated triglycerides | 47 | 45.2 (36.0–54.8) | 31 | 30.1 (22.1–39.5) |
| Reduced HDL-c | 79 | 75.9 (66.9–83.2) | 46 | 44.7 (35.4–54.3) |
| Raised blood pressure | 29 | 27.9 (20.2–37.2) | 19 | 18.5 (12.1–27.0) |
| Elevated fasting blood sugar | 19 | 18.3 (12.0–26.8) | 17 | 16.5 (10.6–24.9) |
| Number of metabolic abnormalities | ||||
| None | 10 | 9.6 (5.3–16.8) | 31 | 30.1 (22.1–39.5) |
| One | 37 | 35.6 (27.0–45.1) | 39 | 37.9 (29.1–47.5) |
| Two | 19 | 18.3 (12.0–26.8) | 17 | 16.5 (10.6–24.9) |
| Three | 19 | 18.3 (12.0–26.8) | 5 | 4.9 (2.1–10.9) |
| Four | 14 | 13.5 (8.2–21.3) | 9 | 8.7 (4.7–15.8) |
| Five | 5 | 4.8 (2.1–10.8) | 2 | 1.9 (0.05–6.8) |
| At least one abnormality | 94 | 90.4 (83.2–94.7) | 72 | 69.9 (60.5–77.9) |
| Metabolic syndrome (≥3 abnormalities) | 38 | 36.5 (27.9–46.1) | 16 | 15.5 (9.8–23.8) |
CI: confidence interval; HDL-c: high density lipoprotein-cholesterol; WC: waist circumference.